DanDrit Biotech USA Inc Stock OTC Bulletin Board
Equities
US2360781015
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
04-24 | Renovaro's RenovaroCube Amends Agreement to Acquire 100% Stake in Cyclomics | MT |
04-18 | Renovaro Inc. Announces Geert Kazemier, MD, PhD, as the New Chairman of its Scientific Advisory Board | CI |
Sales 2022 | - | Sales 2023 | - | Capitalization | 34.41M 47.03M |
---|---|---|---|---|---|
Net income 2022 | -113M -154M | Net income 2023 | -39M -53.3M | EV / Sales 2022 | - |
Net cash position 2022 | 1.99M 2.72M | Net Debt 2023 | 3.9M 5.34M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.89
x | P/E ratio 2023 |
-0.8
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.77% |
Managers | Title | Age | Since |
---|---|---|---|
Mark Dybul
CEO | Chief Executive Officer | 60 | 18-01-22 |
Lester Russell
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-20 |
Greg Duczynski
CTO | Chief Tech/Sci/R&D Officer | - | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregg Alton
BRD | Director/Board Member | 58 | 19-12-31 |
Avram Miller
BRD | Director/Board Member | - | 23-10-10 |
James Sapirstein
BRD | Director/Board Member | 63 | 18-03-05 |
1st Jan change | Capi. | |
---|---|---|
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |